Study Of Fesoterodine In Pediatric Overactive Bladder Patients Aged 8-17 Years

Clinical trial NCT00857896 · COMPLETED

Trial details

NCT number: NCT00857896
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Overactive Bladder Neurogenic Detrusor Overactivity

Start date: 2009-03-01
Primary completion: 2010-12-01
Enrollment: 21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.